双歧杆菌防治鼠伤寒沙门菌感染的实验研究

目的　以小鼠为模型,研究双歧杆菌在体内对鼠伤寒沙门菌（Ｓａｌｍｏｎｅｌｌａ ｔｙｐｈｉｍｕｒｉｕｍ ,ＳＴＭ） 感染的防治作用。方法　分别用大剂量悉复欢、Ｂ．ｂｉｆｉｄｕｍ 、生理盐水（ＮＳ） 给三组小鼠灌胃,再用ＳＴＭ 攻击,观察小鼠经上述不同处理前后肠道双歧杆菌数量和ＳＴＭ 攻击后粪便ＳＴＭ 培养阳性率,阳性标本ＳＴＭ 分离值及小鼠ＳＴＭ 感染率;同时用双歧杆菌、悉复欢、双歧杆菌加悉复欢分别治疗ＳＴＭ 感染的小鼠,观察并比较疗效。结果　１． 大剂量悉复欢使用可使小鼠肠道内双歧杆菌明显降低,而双歧杆菌灌胃则肠道双歧杆菌明显增多。双歧杆菌灌胃的小鼠粪便ＳＴＭ培养阳性率、阳性粪便ＳＴＭ 值明显低于用大剂量悉复欢和ＮＳ 的小鼠,小鼠ＳＴＭ 感染发病率也明显较低。２． 对于ＳＴＭ 感染鼠,双歧杆菌与悉复欢联合治疗效果最好。结论　１． 双歧杆菌在体内对ＳＴＭ 有拮抗作用;能预防和减少ＳＴＭ 感染发生;２． 在ＳＴＭ 感染时,先用悉复欢,再用双歧杆菌可以达到预期疗效,双歧杆菌对鼠伤寒沙门菌感染有辅助治疗作用。     

酪酸梭菌和婴儿型双歧杆菌对霍乱弧菌的拮抗试验

了解酪酸梭菌和婴儿型双歧杆菌单独及混合培养时对霍乱弧菌的拮抗作用。将酪酸梭菌ＬＣＬ１６６和婴儿型双歧杆菌ＬＣＬ１７２分别与霍乱弧菌Ｏ１、Ｏ１３９单独和混合培养,定时对霍乱弧菌计数,并对菌数的对数进行在检验。两株菌混合培养时对霍乱弧菌的抑制效果基本相同,单独和混合培养时对霍乱弧菌的拮抗作用主要由酪酸梭菌引起,酪酸梭菌具有抑制霍乱弧菌的作用。     

酪酸梭菌与婴双歧杆菌对艰难梭菌体外生物拮抗作用的作用

用酪酸梭菌（Clostridium butyricum)和婴双歧杆菌（Bifidobacterium infantis)单独或联合艰难菌（Clostridium difficile)进行试管内的生物拮抗作用,将酪酸梭菌、婴儿双歧杆菌单独或酪酸梭菌和婴儿双歧杆菌联合分别与艰难梭菌以一定的比例等量混合后,接种于GAM液体培养基中进行厌氧培养。证明酪酸梭菌和婴儿双歧杆菌能明显抑制艰难梭菌的生长,并且两菌联合比各自单独培养时显示出更强的生物拮抗作用。     

酪酸梭菌与婴儿型双歧杆菌对产气荚膜梭菌试管内生物拮抗作用的研究

用酪酸权菌（Clostridium butyricum）和婴儿型双歧杆菌（Bifidobacterium Infantis）对产气荚膜梭菌（Clostriduim perfringens）进行试管内的生物拮抗试验。将酪酸梭菌、婴儿型双歧杆菌及酪酸梭菌和婴儿型双歧杆菌分别对产气荚膜酸菌以一定的比例等量混合接种于GAM液体培养基中进行厌氧培养。实验证明酪酸梭菌和婴儿型双歧能明显抑制产气荚膜梭菌的生长,并且比各自单独培养时显示了较强的生物拮抗作用。     

酪酸梭菌与双歧杆菌对肠道致病菌的体外生物拮抗作用

目的：探讨酪酸梭菌和婴儿型双歧杆菌对某些肠道致病菌的拮抗作用,方法：将酪酸梭菌和婴和型双歧杆菌单株菌及两株菌混合后分别与几株肠道致病菌混合接种于GAM液体培养其中进行厌氧培养,通过平板菌落计数法计算肠道致病菌的菌数,结果：经混合培养后肠道致病菌的菌数明显下降,结论：酪酸梭菌LCL166株和婴儿型双歧杆菌LCL172株在体外能明显抑制几株肠道致病菌的生长繁殖。     

对双歧杆菌DM9227株的实验研究——Ⅰ.双歧杆菌DM9227株的试管内生物拮抗作用的研究

本文对由健康婴儿分离的双歧杆菌DM9227株进行了试管内的生物拮抗试验。将双歧杆菌DM9227株分别与金黄色葡萄球菌、产毒性大肠杆菌及侵袭性大肠杆菌以一定的比例等量混合接种于PYG液体培养基中进行厌氧培养。试验证明双歧杆菌DM9227株能明显抑制上述3种细菌的生长繁殖,显示出较强的生物拮抗作用。拮抗机制可能与双歧杆菌DM9227株能产生一定量的醋酸和乳酸,降低培养基的pH,从而抑制该3种菌的生长有关。     

双歧杆菌试管内生物拮抗作用研究

目的 本实验从正常青少年体内分离出1株双歧杆菌,通过试管内研究双歧杆菌对大肠埃希菌和粪肠球菌的生物拮抗作用.为双歧杆菌临床应用及食品开发提供一定的基础理论依据和广阔的市场前景.方法 本项研究以从佳木斯大学健康学生体内分离出1株双歧杆菌为试材,将大肠埃希菌、粪肠球菌接种于PYG液体培养基中,37℃厌氧培养48 h,将菌液浓度利用分光光度计法调到2麦氏.将大肠埃希菌对照组分为10支,分离的双歧杆菌+大肠埃希菌组10支,分离的双歧杆菌对照组10支,分离的双歧杆菌+粪肠球菌组10支,粪肠球菌对照组10支,将以上50个试管全部置于厌氧培养箱内37℃培养48 h,将培养好的大肠埃希菌和粪肠球菌进行梯度稀释,然后用微量移液器吸取标本于每个培养基上滴3滴,每滴滴上由高稀释度向低稀释度,液体量为10 μL的菌液.晾干滴种好的培养基于适宜条件进行培养并选出适合菌落生长的稀释度,计算同一稀释度平均菌落数(x).结果 双歧杆菌12 h时对大肠埃希菌生长无显著性,在24h时检测不到大肠埃希菌的存在.12和24h时粪肠球菌与双歧杆菌混合组与粪肠球菌对照组相比,差异均无统计学意义(P＞0.05).结论 体外对照实验研究该双歧杆菌对大肠埃希菌和粪肠球菌的生物拮抗作用,此株双歧杆菌只对大肠埃希菌有抑制作用,而对粪肠球菌无抑制作用,机制需要深入研究.     

不同因素下双歧杆菌BB-12对变形链球菌拮抗作用的体外研究

目的探讨不同因素下双歧杆菌BB-12对变形链球菌的抑制作用。方法采用液体培养法分别培养双歧杆菌BB-12与变形链球菌,利用紫外分光光度计调节具有相同吸光度值的菌液,观察不同因素下双歧杆菌BB-12对变形链球菌的拮抗作用,使用扫描电镜观察早期变形链球菌生物膜的变化。结果双歧杆菌BB-12在不同因素作用下对变形链球菌均具有拮抗作用,双歧杆菌BB-12能够抑制早期变形链球菌生物膜的形成。结论双歧杆菌BB-12对变形链球菌有拮抗作用。     

党参多糖对双歧杆菌和大肠埃希菌体外生长的影响

目的探讨党参多糖体外对双歧杆菌和大肠埃希菌生长的影响。方法每隔12 h采用分光光度法测600 nm细菌培养液A值,气相色谱法测培养48 h后的双歧杆菌培养液中乙酸含量。结果党参多糖体外对大肠埃希菌没有促进或抑制生长的作用,对双歧杆菌有促进生长的作用,在中药作用下,双歧杆菌代谢的乙酸含量与其数量呈正相关关系。结论党参多糖能够通过促进双歧杆菌的生长,从而增加乙酸的代谢,增强双歧杆菌的定植抗力,对肠道一些致病菌发挥生物拮抗作用。     

双歧杆菌对大肠癌细胞ccL187cAMP,cGMP影响的实验研究

双歧杆菌对维持机体正常微生态平衡具有重要作用。本文研究了长双歧杆菌对大肠癌细胞ｃｃＬ１８７内第二信使ｃＡＭＰ、ｃＧＭＰ浓度的影响,对长双歧杆菌的对数期培养物分别进行下列处理：活菌、死菌、代谢产物作用ｃｃＬ１８７细胞２小时后分别收集ｃｃＬ１８７细胞内的ｃＡＭＰ、ｃＧＭＰ浓度。实验表明长双歧杆菌的不同状态及代谢产物对ｃＡＭＰ、ｃＧＭＰ产生显著影响,且存在时间依赖关系,三种处理作用ｃｃＬ１８７细胞内的ｃ     

The vaginal Bifidobacterium flora in women of reproductive age

The composition of vaginal bifidoflora in 56 clinically healthy women of reproductive age was studied. The study revealed that four species of bifidobacteria, viz. Bifidobacterium bifidum, B. breve, B. adolescentis 2 and B. longum, dominated in the composition of this bifidobacterial population. Nine out of 11 isolated strains were found to be capable of inhibiting indicator microorganisms Staphylococcus aureus and Enterococcus faecalis when tested in vitro; in addition, strains B. adolescentis 2 F1, B. bifidum G1, B. breve P2 and B. longum Z4 inhibited Klebsiella ozaenae, Pseudomonas aeruginosa, Escherichia coli and were also active acid producers. Three of these 4 bifidobacterial strains were capable of adhesion to vaginal epitheliocytes, while B. bifidum G1 was practically incapable of adherence to these cells, similarly to B. bifidum strain 791 of intestinal origin. In addition, the spectra of antibiotic susceptibility varied from strain to strain, but all bifidobacterial strains were susceptible to benzylpenicillin and resistant to lomefloxacin, most of them being also resistant to cyprofloxacin and gentamicin. Thus the data presented in this work are indicative of the possibility and advantages of using bifidobacterial strains belonging to this ecological niche as probiotics for the correction of the microflora of the urogenital tract in females.     

The role of hemagglutination and effect of exopolysaccharide production on bifidobacteria adhesion to Caco-2 cells in vitro

It is believed that an important criterion for a potential probiotic strain is that it is capable of adhering to mucosal surfaces in the human gastrointestinal tract. The purpose of this study was to investigate a possible relationship between exopolysaccharide production and adhesion to Caco-2 cells by Bifidobacterium breve A28 and Bifidobacterium bifidum A10. In a preselection process, the hemagglutination abilities of these bacteria were determined prior to undertaking adhesion studies. B. breve A28, which produces large amounts of EPS (97.00 ± 2.00 mg/l) and has good hemagglutination abilities (+3) was found to adhere strongly to Caco-2 cells. Under gastrointestinal conditions, the high EPS producing- B. breve A28 was found to have better viability and adhesion to Caco-2 cells than the low EPS producing- B. bifidum A10. Also, B. breve A28 was found to be more effective at inhibiting Escherichia coli ATCC 11229 than B. bifidum A10. This investigation showed that high EPS production and adhesion ability may be important in the selection of bifidobacteria as probiotic strains.     

The antagonistic activity of bifidobacteria in vitro and in vivo studied by using gnotobiological technology

The antagonistic activity of 4 strains of bifidobacteria (B. adolescentis 2 F1, B. longum Z4, B. breve R2 and B. bifidum G1), isolated from the vagina of healthy females of the reproductive age, with respect to Escherichia coli, Klebsiella ozaenae, Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa and Gardnerella vaginalis were studied in vitro and in vivo. The in vitro experiments revealed that all above-mentioned bifidobacteria were capable of inhibiting the growth of all indicator bacterial strains. Still of all the bifidobacteria under study had different levels of activity. B. adolescentis strain 2 F1 exhibited the highest inhibiting activity in vitro. In contrast to in vitro experiments, in vivo experiments with B. breve R2 demonstrated its high antagonistic activity with respect to E. coli. The data thus obtained indicate that in the study of antagonistic activity the use of the in vivo model as also expedient, for it is mainly in vivo that probiotic preparations show their activity.     

Antagonistic Action of Lactobacilli and Bifidobacteria in Relation to Staphylococcus aureus and Their Influence on the Immune Response in Cases of Intravaginal Staphylococcosis in Mice

The antibacterial activity of Lactobacillus casei IMV B-7280, Lact. acidophilus IMV B-7279, Bifidobacterium longum VK1, and B. bifidum VK2 strains or their various compositions in relation to Staphylococcus aureus in vitro and on models of experimental intravaginal staphylococcosis of mice was determined. It was found that under the influence of these strains and their various compositions, the in vitro growth of Staph. aureus was inhibited, and the number of colonies of Staph. aureus plated from the vagina of infected mice was significantly reduced. The antibacterial activity of these strains separately and in compositions correlated with their ability to improve the performance of the immune response. These strains were the most effective in the following compositions: Lact. casei IMV B-7280-B. longum VK1-B. bifidum VK2. Strains of Lact. casei IMV B-7280, Lact. acidophilus IMV B-7279, B. bifidum VK2, and B. longum VK1 are prospective components of future probiotic drugs efficient in treating staphylococcosis and for immunity correction.     

The effects of Bifidobacterium bifidum OFR9, a strain resistant to antituberculosis and antileprosy agents,on fecal flora in mice

Since Bifidobacterium bifidum, one of the strains of medical preparations used for human intestinal disorders, is sensitive to rifampicin (RFP) and fluoroquinolones, its therapeutic effect cannot be guaranteed when it is administered concomitantly with these antibiotics. To develop new strains of B. bifidum that are resistant to these drugs, B. bifidum RFR61, which is highly resistant to RFP, was selected by the N-methyl-N'-nitrosoguanidine (MNNG) mutation method. Then, B. bifidum OFR9 was selected in vitro from B. bifidum RFR61 by serial passage to increasing concentrations of ofloxacin (OFLX) on a solid medium. The minimal inhibition concentrations (MIC) of RFP and fluoroquinolones for B. bifidum OFR9 were >256 mg/ml and 16-256 &mgr;g/ml, respectively. We investigated the effects of B. bifidum OFR9 on the fecal bacterial flora of mice administered with both antibiotics and B. bifidum OFR9. The results showed that the concurrent use of B. bifidum OFR9 and antibiotics prevented the decrease of bifidobacteria, and quickly restored the flora to normal as compared with the use of antibiotic or parent strain therapy alone. The survival of Shigella organisms in mouse feces rapidly decreased, and were removed within two days as a result of the oral administration of B. bifidum OFR9.     

Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation

The ability of bifidobacteria to establish in the intestine of mammals is among the main factors considered to be important for achieving probiotic effects. The role of surface molecules from Bifidobacterium bifidum taxon in mucin adhesion capability and the aggregation phenotype of this bacterial species was analyzed. Adhesion to the human intestinal cell line HT29 was determined for a collection of 12 B. bifidum strains. In four of them-B. bifidum LMG13195, DSM20456, DSM20239, and A8-the involvement of surface-exposed macromolecules in the aggregation phenomenon was determined. The aggregation of B. bifidum A8 and DSM20456 was abolished after treatment with proteinase K, this effect being more pronounced for the strain A8. Furthermore, a mucin binding assay of B. bifidum A8 surface proteins showed a high adhesive capability for its transaldolase (Tal). The localization of this enzyme on the surface of B. bifidum A8 was unequivocally demonstrated by immunogold electron microscopy experiments. The gene encoding Tal from B. bifidum A8 was expressed in Lactococcus lactis, and the protein was purified to homogeneity. The pure protein was able to restore the autoaggregation phenotype of proteinase K-treated B. bifidum A8 cells. A recombinant L. lactis strain, engineered to secrete Tal, displayed a mucin- binding level more than three times higher than the strain not producing the transaldolase. These findings suggest that Tal, when exposed on the cell surface of B. bifidum, could act as an important colonization factor favoring its establishment in the gut.     

Feruloyl oligosaccharides stimulate the growth of Bifidobacterium bifidum

Insoluble dietary fiber from wheat bran contains some feruloyl groups linked to the arabinose residues in the cell wall arabinoxylan. Treatment of wheat bran insoluble dietary fiber with xylanase from Bacillus subtilis yielded feruloyl oligosacchairdes, which were purified with Amberlite XAD-2. Saponification of the feruloyl oligosaccharides released ferulic acid and arabinoxylan oligosaccharides which consist of arabinose and xylose. The effect of the feruloyl oligosacchairdes on the growth of Bifidobacterium bifidum F-35 was investigated in vitro. The B. bifidum produced acid when cultivated anaerobically in TPY broth with 0.5% feruloyl oligosacchairdes as the carbohydrate source. The biomass yield of the B. bifidum increased with increasing the concentration of feruloyl oligosaccharides in TPY broth. The maximum cell growth was increased by 50% in TPY broth supplemented with 0.1% feruloyl oligosaccharides compared to TPY broth. These results indicated that the growth of B. bifidum F-35 was promoted by the feruloyl oligosaccharides from wheat bran insoluble dietary fiber, and not suppressed by the ferulic acid moiety of them.     

Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains

To characterize the ability of bifidobacteria to affect the production of macrophage-derived cytokines, a murine macrophage-like cell line, J774.1, was cultured in the presence of 27 strains of heat-inactivated bifidobacteria. Bifidobacterium adolescentis and B. longum, known as adult-type bifidobacteria, induced significantly more pro-inflammatory cytokine secretion, IL-12 and TNF-alpha, by J774.1 cells, than did the infant-type bifidobacteria, B. bifidum, B. breve, and B. infantis (P<0.01). In contrast, B. adolescentis did not stimulate the production of anti-inflammatory IL-10 from J774.1 cells as the other tested bacteria did. The results suggest that the adult-type bifidobacteria, especially B. adolescentis, may be more potent to amplify but less able to down-regulate the inflammatory response.     

Complete genome sequence of Bifidobacterium bifidum S17

Here, we report on the first completely annotated genome sequence of a Bifidobacterium bifidum strain. B. bifidum S17, isolated from feces of a breast-fed infant, was shown to strongly adhere to intestinal epithelial cells and has potent anti-inflammatory activity in vitro and in vivo. The genome sequence will provide new insights into the biology of this potential probiotic organism and allow for the characterization of the molecular mechanisms underlying its beneficial properties.